Letter: Optimising Hepatitis B Vaccination in Inflammatory Bowel Disease – Expanding Strategies Beyond Double‐Dose Recombinant Vaccination
Alimentary Pharmacology & Therapeutics · 2026-06 · 63 (11) · 1579-1581
DOI: 10.1111/apt.70651 ↗Kurz gefasst
Leserbrief in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 31.03.2026. Verfasst von Yash Hegde und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Wisconsin - Madison, School of Medicine & Public Health, Madison, Wisconsin, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Medicine, University of Wisconsin - Madison, School of Medicine & Public Health, Madison, Wisconsin, USA.
- Department of Medicine, Division of Gastroenterology and Hepatology, University of Wisconsin - Madison, School of Medicine & Public Health, Madison, Wisconsin, USA.
ORCID-Profile: Yash Hegde, Freddy Caldera
Zitieren
APA
Hegde, Y., & Caldera, F. (2026). Letter: Optimising Hepatitis B Vaccination in Inflammatory Bowel Disease – Expanding Strategies Beyond Double‐Dose Recombinant Vaccination. Alimentary Pharmacology & Therapeutics, 63(11), 1579-1581. https://doi.org/10.1111/apt.70651
Vancouver
Hegde Y, Caldera F. Letter: Optimising Hepatitis B Vaccination in Inflammatory Bowel Disease – Expanding Strategies Beyond Double‐Dose Recombinant Vaccination. Alimentary Pharmacology & Therapeutics. 2026;63(11):1579-1581. doi:10.1111/apt.70651
BibTeX
@article{Hegde2026,
author = {Hegde, Yash and Caldera, Freddy},
title = {Letter: Optimising Hepatitis B Vaccination in Inflammatory Bowel Disease – Expanding Strategies Beyond Double‐Dose Recombinant Vaccination},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {63},
number = {11},
pages = {1579--1581},
doi = {10.1111/apt.70651}
}
EUVIMED